Cellular Biomedicine Group (Cellular Biomedicine Group) Other Long-Term Liabilities : $16.47 Mil (As of Sep. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cellular Biomedicine Group Other Long-Term Liabilities?

Cellular Biomedicine Group's other long-term liabilities for the quarter that ended in Sep. 2020 was $16.47 Mil.

Cellular Biomedicine Group's quarterly other long-term liabilities declined from Mar. 2020 ($17.20 Mil) to Jun. 2020 ($16.58 Mil) and declined from Jun. 2020 ($16.58 Mil) to Sep. 2020 ($16.47 Mil).

Cellular Biomedicine Group's annual other long-term liabilities increased from Dec. 2017 ($0.18 Mil) to Dec. 2018 ($14.32 Mil) and increased from Dec. 2018 ($14.32 Mil) to Dec. 2019 ($17.93 Mil).

Cellular Biomedicine Group Other Long-Term Liabilities Historical Data

The historical data trend for Cellular Biomedicine Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellular Biomedicine Group Other Long-Term Liabilities Chart

Cellular Biomedicine Group Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Other Long-Term Liabilities

Get a 7-Day Free Trial

Cellular Biomedicine Group Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cellular Biomedicine Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cellular Biomedicine Group Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cellular Biomedicine Group's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellular Biomedicine Group (Cellular Biomedicine Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellular Biomedicine Group Inc (NAS:CBMG) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1345 Avenue of Americas, 15th Floor, New York, NY, USA, 10105

Website

http://www.cellbiomedgroup.com

Cellular Biomedicine Group Inc is a biotechnology company focused on the development of proprietary cell therapies for the treatment of cancer and degenerative diseases. The company has two major cell platforms: immune cell therapy for treating a broad range of cancers using cancer vaccines, Chimeric Antigen Receptor T-cell technologies, and anti-PD-1 technologies; and human-adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases. The immuno-oncology and stem cell research team is based in both China and the United States.

Executives

Ag Novartis	10 percent owner	LICHTSTRASSE 35, BASEL V8 CH 4056
Pharma Ag Novartis	10 percent owner	LICHTSTRASSE 35, CH-4002, BASEL V8
Edward T Schafer	director	1400 31ST AVENUE SW, SUITE 60, MINOT ND 58701
Wen Tao Liu	director	530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Terry Belmont	director	530 UNIVERSITY DRIVE PALO ALTO CA 94301
Au Chun Kwok Alan	director	C/O CELLULAR BIOMEDICINE GROUP, INC. 530 UNIVERSITY AVENUE, #17 NEW YORK NY 94301
Hansheng Zhou	director	369 LUMO ROAD HONGSHAN DISTRICT WUHAN F4 430074
Gang Jacky Ji	director	XIXI RONGZHUANG 27-3 JINGCHANG ROAD, YUHANG DISTRICT, HANGZHOU, ZHEJIANG F4 311100
Viktor Pan	10 percent owner	HELI XI LU 183 NO. 531 SHANGHAI F4 201317
Srl Opea	director	VIA CESARE BATTISTA 1 MILAN L6 20122
Zheng Zhou	10 percent owner	FLAT B, 25/F, TOWER 6, MARINELLA 9 WELFARE ROAD, ABERDEEN HONG KONG K3 00000
Sailing Capital Overseas Investments Fund, Lp	10 percent owner	C/O UNIT 2006-08, 20F HARBOUR CENTRE 25 HARBOUR ROAD WAN CHAI K3 00000
Maplebrook Ltd	10 percent owner	P.O. BOX 31119 GRAND PAVILLION HIBISCUS WAY, 802 WEST BAY ROAD GRAND CAYMAN E9 KY1-1205
Tf Venture Capital Management Co., Ltd.	10 percent owner	PO BOX 472, 2ND FLOOR, HARBOUR PLACE 103 SOUTH CHURCH STREET, GEORGE TOWN GRAND CAYMAN E9 KY1-1106
Winsor Capital Ltd	10 percent owner	TRINITY CHAMBERS PO BOX 4301, ROAD TOWN TORTOLA D8 00000